1
|
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association.
|
Postgrad Med J
|
1993
|
4.28
|
2
|
The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
|
Eye (Lond)
|
2002
|
2.13
|
3
|
Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times.
|
Eye (Lond)
|
2007
|
2.12
|
4
|
Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
|
J Clin Endocrinol Metab
|
1998
|
1.72
|
5
|
Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension.
|
Br J Ophthalmol
|
1989
|
1.63
|
6
|
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
|
Br J Ophthalmol
|
1982
|
1.52
|
7
|
Does microvascular disease predict macrovascular events in type 2 diabetes?
|
Atherosclerosis
|
2011
|
1.38
|
8
|
beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion.
|
Br J Ophthalmol
|
1983
|
1.16
|
9
|
Nine year follow-up study of morbidity and mortality in retinal vein occlusion.
|
Eye (Lond)
|
2000
|
1.15
|
10
|
Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion.
|
Trans Ophthalmol Soc U K
|
1985
|
1.07
|
11
|
Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNA(Leu) A to G mutation.
|
Ophthalmology
|
1999
|
1.05
|
12
|
Asteroid hyalosis and photographic diabetic retinopathy screening.
|
Diabet Med
|
2010
|
1.05
|
13
|
Plasma total homocysteine and retinal vascular disease.
|
Eye (Lond)
|
2000
|
1.05
|
14
|
The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
|
J Clin Endocrinol Metab
|
1999
|
1.01
|
15
|
Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids.
|
Postgrad Med J
|
1996
|
0.99
|
16
|
High-fibre and low-fat diets in diabetes mellitus.
|
Br J Nutr
|
1981
|
0.98
|
17
|
Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy.
|
Eye (Lond)
|
1995
|
0.98
|
18
|
MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
|
Lancet
|
2001
|
0.97
|
19
|
Retinal vein occlusion: C-reactive protein and arterial hypertension.
|
Acta Ophthalmol (Copenh)
|
1984
|
0.97
|
20
|
Dietary fibre, sodium, and blood pressure.
|
Br Med J
|
1980
|
0.97
|
21
|
Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.
|
Eye (Lond)
|
2011
|
0.96
|
22
|
Pupillary dilatation and driving in diabetic patients.
|
Diabet Med
|
1998
|
0.95
|
23
|
Homocysteine, folates, and the eye.
|
Eye (Lond)
|
2007
|
0.95
|
24
|
Sex hormone preparations and retinal vein occlusion.
|
Eye (Lond)
|
1997
|
0.94
|
25
|
Retinal vascular abnormalities in the hyperlipidaemias.
|
Trans Ophthalmol Soc U K
|
1981
|
0.92
|
26
|
Hypertension and diabetic retinopathy--what's the story?
|
Br J Ophthalmol
|
1999
|
0.92
|
27
|
A controlled trial of a high fibre, low fat and low sodium diet for mild hypertension in Type 2 (non-insulin-dependent) diabetic patients.
|
Diabetologia
|
1984
|
0.91
|
28
|
Medical conditions underlying recurrence of retinal vein occlusion.
|
Br J Ophthalmol
|
1985
|
0.88
|
29
|
Long-term follow-up of the treatment of essential hypertension with a high-fibre, low-fat and low-sodium dietary regimen.
|
Hum Nutr Clin Nutr
|
1985
|
0.86
|
30
|
Effect of a high fibre, high carbohydrate dietary regimen on serum lipids and lipoproteins in type II hypertensive diabetic patients.
|
Diabetes Res
|
1984
|
0.85
|
31
|
Prevalence of hypertension in white, black and Asian diabetics in a district hospital diabetic clinic.
|
Diabet Med
|
1985
|
0.83
|
32
|
Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study.
|
J Hum Hypertens
|
1996
|
0.83
|
33
|
Differences in lipid and lipoprotein levels in white, black and Asian non-insulin dependent (type 2) diabetics with hypertension.
|
Diabetes Res
|
1987
|
0.82
|
34
|
Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme.
|
Eye (Lond)
|
2009
|
0.82
|
35
|
Cigarette smoking, blood pressure and the control of blood glucose in the development of diabetic retinopathy.
|
Diabetes Res
|
1985
|
0.80
|
36
|
Diabetic eye disease: a natural history study.
|
Eye (Lond)
|
1997
|
0.80
|
37
|
Is measurement of blood pressure worthwhile in the diabetic eye clinic?
|
Eye (Lond)
|
2005
|
0.80
|
38
|
Severe hypertension with lone bilateral papilloedema: a variant of malignant hypertension.
|
Blood Press
|
1995
|
0.78
|
39
|
The ethnic prevalence of hypertension in a diabetic clinic.
|
Postgrad Med J
|
1983
|
0.78
|
40
|
The effects of a high fibre, low fat and low sodium dietary regime on diabetic hypertensive patients of different ethnic groups.
|
Postgrad Med J
|
1983
|
0.78
|
41
|
Malignant change in dermatitis artefacta.
|
Postgrad Med J
|
1993
|
0.78
|
42
|
Diabetic retinopathy without diabetes.
|
Diabet Med
|
2007
|
0.77
|
43
|
Risk factors for peripheral vascular disease in hypertensive subjects with type 2 diabetes mellitus.
|
Diabet Med
|
1992
|
0.77
|
44
|
Comparison of the hypotensive and metabolic effects of bendrofluazide therapy and a high fibre, low fat, low sodium diet in diabetic subjects with mild hypertension.
|
J Hypertens
|
1984
|
0.77
|
45
|
Medical treatment of diabetic retinopathy.
|
Eye (Lond)
|
2003
|
0.77
|
46
|
The National Diabetic Retinopathy Laser Treatment Audit: implications for clinical practice in 1998.
|
Eye (Lond)
|
1998
|
0.76
|
47
|
Comparison of the hypotensive and metabolic effects of metoprolol therapy with a high fibre, low sodium, low fat diet in hypertensive type 2 diabetic subjects.
|
Diabetes Res
|
1984
|
0.76
|
48
|
Cardiovascular therapies and their role in diabetic eye disease.
|
Diabet Med
|
2005
|
0.75
|
49
|
Diagnosis and management of migraine. Differential diagnosis may be different in patients presenting to an ophthalmologist.
|
BMJ
|
1996
|
0.75
|
50
|
Patient compliance and diabetes control.
|
Lancet
|
1991
|
0.75
|
51
|
The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.
|
Postgrad Med J
|
1991
|
0.75
|
52
|
Hypertension and dietary fat.
|
J Hum Hypertens
|
1989
|
0.75
|
53
|
Effect of a high carbohydrate, low sodium and low fat diet in type 2 diabetics with moderate hypertension.
|
Int J Obes
|
1986
|
0.75
|
54
|
A toxic testicle.
|
Lancet
|
2000
|
0.75
|
55
|
Treatment of hypertension in patients with type 2 diabetes: a review of the recent evidence.
|
J Hum Hypertens
|
1999
|
0.75
|
56
|
High fibre, low sodium and low fat diet in white and black type 2 diabetics with mild hypertension.
|
Diabetes Res
|
1986
|
0.75
|
57
|
The acute and long-term ocular effects of accelerated hypertension: a clinical and electrophysiological study.
|
Eye (Lond)
|
1996
|
0.75
|
58
|
The non-drug treatment of hypertension in the diabetic patient.
|
J Hum Hypertens
|
1991
|
0.75
|
59
|
Are there medical conditions specifically underlying the development of rubeosis in central retinal vein occlusion?
|
Eye (Lond)
|
1993
|
0.75
|
60
|
Management of retinal vein occlusion.
|
Br J Hosp Med
|
1993
|
0.75
|
61
|
Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?
|
Eye (Lond)
|
2004
|
0.75
|
62
|
Ophthalmological complications of the hypertriglyceridaemias.
|
Trans Ophthalmol Soc U K
|
1980
|
0.75
|
63
|
Dietary sodium restriction in the treatment of mild hypertension.
|
Proc Nutr Soc
|
1986
|
0.75
|
64
|
Hydronephrosis and a hard neck swelling.
|
Postgrad Med J
|
2001
|
0.75
|
65
|
Nutrition and hypertension.
|
Ann Nutr Metab
|
1985
|
0.75
|
66
|
The effect of a high fibre, low fat, low sodium diet on diabetics with intermittent claudication.
|
Br J Clin Pract
|
1986
|
0.75
|